Shingo Eikawa

1.3k total citations · 1 hit paper
21 papers, 987 citations indexed

About

Shingo Eikawa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Shingo Eikawa has authored 21 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Shingo Eikawa's work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shingo Eikawa is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shingo Eikawa collaborates with scholars based in Japan, United States and Switzerland. Shingo Eikawa's co-authors include Heiichiro Udono, Eiichi Nakayama, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Yuki Kunisada, Takenori Uehara, Akiko Uenaka, Mikio Oka and Yoshihiro Ohue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Shingo Eikawa

20 papers receiving 979 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

2015 433 citations Shingo Eikawa, Mikako Nishida et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shingo Eikawa Japan	11	501	443	433	174	106	21	987
Akio Yamasaki Japan	15	477 1.0×	523 1.2×	391 0.9×	220 1.3×	126 1.2×	37	1.1k
Christa Pfeifhofer‐Obermair Austria	19	433 0.9×	295 0.7×	504 1.2×	196 1.1×	63 0.6×	31	1.1k
Sara Pensa United Kingdom	13	544 1.1×	563 1.3×	260 0.6×	215 1.2×	42 0.4×	18	1.1k
Toshiyuki Tenjo Japan	7	762 1.5×	488 1.1×	171 0.4×	132 0.8×	109 1.0×	12	1.1k
Ana P. Costa‐Pereira United Kingdom	18	468 0.9×	506 1.1×	411 0.9×	138 0.8×	44 0.4×	22	986
Nadège Kindt Belgium	18	242 0.5×	245 0.6×	472 1.1×	131 0.8×	57 0.5×	30	856
Baoxiang Guan United States	13	588 1.2×	537 1.2×	335 0.8×	308 1.8×	120 1.1×	20	1.1k
Jami Willette‐Brown United States	20	367 0.7×	228 0.5×	914 2.1×	171 1.0×	48 0.5×	34	1.3k
Chang Xian Li China	17	451 0.9×	300 0.7×	427 1.0×	266 1.5×	191 1.8×	29	1.2k
Russell Ericksen United States	14	523 1.0×	305 0.7×	144 0.3×	271 1.6×	184 1.7×	22	1.0k

Countries citing papers authored by Shingo Eikawa

Since Specialization

Citations

This map shows the geographic impact of Shingo Eikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Eikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Eikawa more than expected).

Fields of papers citing papers by Shingo Eikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Eikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Eikawa. The network helps show where Shingo Eikawa may publish in the future.

Co-authorship network of co-authors of Shingo Eikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Eikawa. A scholar is included among the top collaborators of Shingo Eikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Eikawa. Shingo Eikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anker, Jonathan F., Sumanta K. Pal, Seunghee Kim‐Schulze, et al.. (2023). Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. Journal for ImmunoTherapy of Cancer. 11(8). e007613–e007613. 7 indexed citations

Eikawa, Shingo, Nahoko Tomonobu, Nobuo Kajitani, et al.. (2020). Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis. Scientific Reports. 10(1). 14928–14928. 38 indexed citations

Takahara, Masahiro, Akinobu Takaki, Sakiko Hiraoka, et al.. (2019). Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation. Scientific Reports. 9(1). 11934–11934. 65 indexed citations

Kunisada, Yuki, Shingo Eikawa, Nahoko Tomonobu, et al.. (2017). Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug. EBioMedicine. 25. 154–164. 120 indexed citations

Watanabe, Mototsugu, Shingo Eikawa, Kazuhiko Shien, et al.. (2017). Abstract 5592: Metformin improves immune function of exhausted peripheral CD8+ T cells derived from cancer patients. Cancer Research. 77(13_Supplement). 5592–5592. 3 indexed citations

Tomonobu, Nahoko, Shingo Eikawa, & Heiichiro Udono. (2017). Metformin-dependent metabolic reprogramming contributes to efficient anti-tumor immunity.. PubMed. 75(2). 323–328.

Eikawa, Shingo & Heiichiro Udono. (2017). [Metabolic Competition in Tumor Microenvironment].. PubMed. 44(11). 972–976. 3 indexed citations

Ariyoshi, Yuichi, Masami Watanabe, Shingo Eikawa, et al.. (2016). The induction of antigen-specific CTL by in situ Ad-REIC gene therapy. Gene Therapy. 23(5). 408–414. 3 indexed citations

Watanabe, Mototsugu, Hiromasa Yamamoto, Shingo Eikawa, et al.. (2016). Study about the Efficacy of Metformin to Immune Function in Cancer Patients.. PubMed. 70(4). 327–30. 4 indexed citations

10.

Eikawa, Shingo, Mikako Nishida, Shusaku Mizukami, et al.. (2015). Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proceedings of the National Academy of Sciences. 112(6). 1809–1814. 433 indexed citations breakdown →

11.

Eikawa, Shingo, Akihiro Hosoi, Hirokazu Matsushita, et al.. (2015). Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient. PLoS ONE. 10(8). e0136086–e0136086. 5 indexed citations

12.

Kurose, Koji, Yoshihiro Ohue, Eiichi Sato, et al.. (2014). Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760). Journal of Thoracic Oncology. 10(1). 74–83. 48 indexed citations

13.

Eikawa, Shingo, Shusaku Mizukami, & Heiichiro Udono. (2014). Monitoring Multifunctionality of Immune-Exhausted CD8 T Cells in Cancer Patients. Methods in molecular biology. 1142. 11–17. 7 indexed citations

14.

Eikawa, Shingo & Heiichiro Udono. (2014). [Regulation of T-cell immune exhaustion and cancer immunotherapy].. PubMed. 41(9). 1066–70. 2 indexed citations

15.

Kurose, Koji, Shingo Eikawa, Yoshihiro Ohue, et al.. (2013). Abstract 4732: Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.. Cancer Research. 73(8_Supplement). 4732–4732. 3 indexed citations

16.

Eikawa, Shingo, Kazuhiro Kakimi, Midori Isobe, et al.. (2012). Induction of CD8 T‐cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20‐mer NY‐ESO‐1f (NY‐ESO‐1 91‐110) peptide. International Journal of Cancer. 132(2). 345–354. 24 indexed citations

17.

Kato, Yu, Chiaki Kajiwara, Ikuo Ishige, et al.. (2012). HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation. Autoimmune Diseases. 2012. 1–10. 21 indexed citations

18.

Ohue, Yoshihiro, Shingo Eikawa, Midori Isobe, et al.. (2011). Spontaneous antibody, and CD4 and CD8 T‐cell responses against XAGE‐1b (GAGED2a) in non‐small cell lung cancer patients. International Journal of Cancer. 131(5). E649–58. 33 indexed citations

19.

Eikawa, Shingo, et al.. (2010). Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6. The Journal of Immunology. 185(11). 6734–6740. 53 indexed citations

20.

Isobe, Midori, Shingo Eikawa, Akiko Uenaka, et al.. (2009). Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient.. PubMed. 9. 8–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact